MCUJF
Price
$0.82
Change
+$0.11 (+15.49%)
Updated
Sep 19 closing price
Capitalization
8.23M
MEDXF
Price
$1.99
Change
-$0.14 (-6.57%)
Updated
Sep 26 closing price
Capitalization
64.09M
38 days until earnings call
Interact to see
Advertisement

MCUJF vs MEDXF

Header iconMCUJF vs MEDXF Comparison
Open Charts MCUJF vs MEDXFBanner chart's image
Medicure
Price$0.82
Change+$0.11 (+15.49%)
Volume$113
Capitalization8.23M
Medexus Pharmaceuticals
Price$1.99
Change-$0.14 (-6.57%)
Volume$21.67K
Capitalization64.09M
MCUJF vs MEDXF Comparison Chart in %
Loading...
MCUJF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MEDXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MCUJF vs. MEDXF commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MCUJF is a Hold and MEDXF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (MCUJF: $0.82 vs. MEDXF: $1.99)
Brand notoriety: MCUJF and MEDXF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: MCUJF: 7% vs. MEDXF: 147%
Market capitalization -- MCUJF: $8.23M vs. MEDXF: $64.09M
MCUJF [@Pharmaceuticals: Generic] is valued at $8.23M. MEDXF’s [@Pharmaceuticals: Generic] market capitalization is $64.09M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MCUJF’s FA Score shows that 1 FA rating(s) are green whileMEDXF’s FA Score has 1 green FA rating(s).

  • MCUJF’s FA Score: 1 green, 4 red.
  • MEDXF’s FA Score: 1 green, 4 red.
According to our system of comparison, MCUJF is a better buy in the long-term than MEDXF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MCUJF’s TA Score shows that 2 TA indicator(s) are bullish while MEDXF’s TA Score has 6 bullish TA indicator(s).

  • MCUJF’s TA Score: 2 bullish, 6 bearish.
  • MEDXF’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, MEDXF is a better buy in the short-term than MCUJF.

Price Growth

MCUJF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while MEDXF (@Pharmaceuticals: Generic) price change was -9.75% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.18%. For the same industry, the average monthly price growth was +24.24%, and the average quarterly price growth was +67.33%.

Reported Earning Dates

MEDXF is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.18% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MEDXF($64.1M) has a higher market cap than MCUJF($8.23M). MEDXF has higher P/E ratio than MCUJF: MEDXF (99.50) vs MCUJF (11.51). MCUJF YTD gains are higher at: 31.484 vs. MEDXF (-17.598). MEDXF has higher annual earnings (EBITDA): 15.9M vs. MCUJF (1.45M). MEDXF has more cash in the bank: 9.33M vs. MCUJF (4.74M). MCUJF has less debt than MEDXF: MCUJF (1.09M) vs MEDXF (21.9M). MEDXF has higher revenues than MCUJF: MEDXF (106M) vs MCUJF (23.2M).
MCUJFMEDXFMCUJF / MEDXF
Capitalization8.23M64.1M13%
EBITDA1.45M15.9M9%
Gain YTD31.484-17.598-179%
P/E Ratio11.5199.5012%
Revenue23.2M106M22%
Total Cash4.74M9.33M51%
Total Debt1.09M21.9M5%
FUNDAMENTALS RATINGS
MCUJF vs MEDXF: Fundamental Ratings
MCUJF
MEDXF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
81
Overvalued
PROFIT vs RISK RATING
1..100
98100
SMR RATING
1..100
9490
PRICE GROWTH RATING
1..100
4362
P/E GROWTH RATING
1..100
249
SEASONALITY SCORE
1..100
3350

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MCUJF's Valuation (63) in the null industry is in the same range as MEDXF (81). This means that MCUJF’s stock grew similarly to MEDXF’s over the last 12 months.

MCUJF's Profit vs Risk Rating (98) in the null industry is in the same range as MEDXF (100). This means that MCUJF’s stock grew similarly to MEDXF’s over the last 12 months.

MEDXF's SMR Rating (90) in the null industry is in the same range as MCUJF (94). This means that MEDXF’s stock grew similarly to MCUJF’s over the last 12 months.

MCUJF's Price Growth Rating (43) in the null industry is in the same range as MEDXF (62). This means that MCUJF’s stock grew similarly to MEDXF’s over the last 12 months.

MEDXF's P/E Growth Rating (9) in the null industry is in the same range as MCUJF (24). This means that MEDXF’s stock grew similarly to MCUJF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MCUJFMEDXF
RSI
ODDS (%)
Bullish Trend 3 days ago
64%
Bullish Trend 3 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 3 days ago
81%
Momentum
ODDS (%)
Bearish Trend 3 days ago
72%
Bearish Trend 3 days ago
78%
MACD
ODDS (%)
Bullish Trend 3 days ago
63%
Bearish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
60%
Bearish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
61%
Bearish Trend 3 days ago
82%
Advances
ODDS (%)
N/A
Bullish Trend 26 days ago
83%
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
77%
Bullish Trend 3 days ago
78%
Aroon
ODDS (%)
Bearish Trend 3 days ago
75%
Bullish Trend 3 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
MCUJF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MEDXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PJT182.861.70
+0.94%
PJT Partners
BKR50.520.42
+0.84%
Baker Hughes Company
QTTB1.890.01
+0.53%
Q32 Bio
BBDC8.95-0.06
-0.67%
Barings BDC
INR13.76-0.21
-1.50%
Infinity Natural Resources Inc

MCUJF and

Correlation & Price change

A.I.dvisor tells us that MCUJF and LVRLF have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MCUJF and LVRLF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MCUJF
1D Price
Change %
MCUJF100%
N/A
LVRLF - MCUJF
14%
Poorly correlated
N/A
MVMDF - MCUJF
11%
Poorly correlated
N/A
MEDXF - MCUJF
4%
Poorly correlated
-6.57%
KHTRF - MCUJF
3%
Poorly correlated
N/A
INDV - MCUJF
3%
Poorly correlated
+4.87%
More

MEDXF and

Correlation & Price change

A.I.dvisor tells us that MEDXF and LBTSF have been poorly correlated (+10% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MEDXF and LBTSF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MEDXF
1D Price
Change %
MEDXF100%
-6.57%
LBTSF - MEDXF
10%
Poorly correlated
N/A
MRMD - MEDXF
9%
Poorly correlated
+2.14%
MKGAF - MEDXF
7%
Poorly correlated
+1.28%
MCUJF - MEDXF
4%
Poorly correlated
N/A
MEDIF - MEDXF
2%
Poorly correlated
-2.58%
More